Related Experiment Video
Updated: Sep 14, 2025
Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
Published on: September 6, 2024
Organoid models in oncology: advancing precision cancer therapy and vaccine development
Yuxuan Xiao1,2,3, Yutao Li1,2,3, Xilin Jing1,2,3
1Department of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, China.
Abstract:
Organoids are three-dimensional stem cell-derived models that offer a more physiologically relevant representation of tumor biology compared to traditional two-dimensional cell cultures or animal models. Organoids preserve the complex tissue architecture and cellular diversity of human cancers, enabling more accurate predictions of tumor growth, metastasis, and drug responses. Integration with microfluidic platforms, such as organ-on-a-chip systems, further enhances the ability to model tumor-environment interactions in real-time. Organoids facilitate in-depth exploration of tumor heterogeneity, molecular mechanisms, and the development of personalized treatment strategies when coupled with multi-omics technologies. Organoids provide a platform for investigating tumor-immune cell interactions, which aid in the design and testing of immune-based therapies and vaccines. Taken together, these features position organoids as a transformative tool in advancing cancer research and precision medicine.
Insights
Organoids, 3D stem cell models, offer superior tumor biology insights over traditional methods. These advanced models enhance cancer research and personalized medicine by improving predictions of tumor growth and drug responses.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Stem Cell Biology
Background:
- Traditional 2D cell cultures and animal models have limitations in representing human tumor complexity.
- Organoids represent a significant advancement in modeling cancer biology.
- Understanding tumor microenvironment interactions is crucial for effective cancer treatment.
Purpose of the Study:
- To highlight the capabilities of organoids in cancer research.
- To emphasize the role of organoids in advancing precision medicine.
- To showcase organoids as a transformative tool in oncology.
Main Methods:
- Utilizing three-dimensional stem cell-derived organoids.
- Integrating organoids with microfluidic platforms (organ-on-a-chip systems).
- Coupling organoids with multi-omics technologies.
Main Results:
- Organoids provide physiologically relevant tumor models with preserved architecture and cellular diversity.
- Organoids enable accurate prediction of tumor growth, metastasis, and drug responses.
- Organoids facilitate the study of tumor heterogeneity, molecular mechanisms, and tumor-immune interactions.
Conclusions:
- Organoids are a powerful platform for in-depth cancer research.
- Organoid technology is pivotal for developing personalized cancer treatments.
- Organoids significantly advance the field of precision medicine and immune-based therapies.
Related Concept Videos
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:27Tumor Immunotherapy